Amygdalin

The medical consensus and regulatory environment reflect the high risk-to-benefit ratio of this compound:

A disaccharide consisting of two glucose molecules, one benzaldehyde unit, and one hydrocyanic acid unit. amygdalin

The most significant concern regarding amygdalin is . When ingested, amygdalin is broken down by enzymes in the human digestive tract, releasing hydrogen cyanide. The medical consensus and regulatory environment reflect the